Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

More than 12 million Americans suffer with sleep apnea, a potentially serious sleep disorder that causes your breathing to start and stop during rest and can lead to heart disease, stroke and diabetes ...

Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat sleep apnea. It's taken before bedtime to help keep airways open during ...

Tens of millions of people in the United States struggle with obstructive sleep apnea, a condition that occurs when the throat muscles narrow during sleep, leading to temporary pauses in breathing ...

A new pill for sleep apnea could offer hope for those struggling with CPAP machines, according to leading researchers.

Does a Cambridge startup have a pill that can treat sleep apnea? Last week, Apnimed, a little-known pharma startup founded in 2017, announced encouraging results from its clinical trial of a new drug ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, while effective, are often hindered by poor ...

A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients ...